Page last updated: 2024-10-30

metaproterenol and Bright Disease

metaproterenol has been researched along with Bright Disease in 2 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schirmeister, J1
Decot, M1
Hallauer, W1
Willmann, H1
Börner, H1
Falkenhagen, D1
Rohmann, H1
Krüger, M1

Other Studies

2 other studies available for metaproterenol and Bright Disease

ArticleYear
[Beta-receptors and renal hemodynamics in humans].
    Arzneimittel-Forschung, 1966, Volume: 16, Issue:7

    Topics: Bronchodilator Agents; Chemoreceptor Cells; Diuresis; Glomerular Filtration Rate; Glomerulonephritis

1966
[Behavior of plasms renin activity, hemodynamic parameters and clearance values as influenced by orciprenaline and propranolol in patients with limited kidney function].
    Zeitschrift fur Urologie und Nephrologie, 1976, Volume: 69, Issue:12

    Topics: Adult; Angina Pectoris; Chronic Disease; Female; Glomerulonephritis; Hemodynamics; Humans; Kidney Di

1976